Contributions of TierTwoTansy

Contributions by TierTwoTansy, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,855 edits includes activity predating the current log.

1. 04:52, 18 Jul 2026 (diff | hist) Peptide harm reduction 4,800 ±0 m ce
2. 11:40, 24 Jun 2026 (diff | hist) Global access disparity 4,391 ±0 m add the compounded-alternative point with its regulatory caveat
3. 01:45, 10 Jun 2026 (diff | hist) Prescribing information 4,506 ±0 clarify that a discontinued shortage listing changed the compounding position
4. 08:40, 7 Apr 2026 (diff | hist) Global access disparity 4,391 ±0 m give the cost per unit of effect rather than only the cost
5. 02:36, 11 Mar 2026 (diff | hist) Peptide harm reduction 4,800 ±0 m add the harm-reduction cross-link
6. 03:48, 22 Feb 2026 (diff | hist) Prior authorisation 4,216 ±0 m clarify that the figures are for one country only
7. 14:11, 24 Oct 2025 (diff | hist) PolyPeptide Group (Hangzhou) 8,087 +201 add the lead time for catalogue lines, as reported
8. 10:51, 11 Aug 2025 (diff | hist) SinoPep 5,978 ±0 close an unbalanced quotation mark
9. 04:10, 28 Mar 2025 (diff | hist) Peptide harm reduction 3,320 ±0 expand §What documentation can and cannot fix
10. 15:19, 11 Mar 2025 (diff | hist) Prior authorisation 2,250 ±0 m space between number and unit per PP:MOS
11. 09:00, 26 Feb 2025 (diff | hist) Flourishglobal Peptide Biotech 2,137 +2,137 N start organisation article — registry facts and product scope only
12. 04:03, 20 Feb 2025 (diff | hist) Cost per milligram 2,123 ±0 rm the specific plan recommendation; out of scope
13. 12:51, 11 Feb 2025 (diff | hist) Lot traceability 4,002 ±0 add category for certificates of analysis
14. 05:22, 27 Jan 2025 (diff | hist) Cost per milligram 1,917 +33 add the prior-authorisation criterion as attributed to the payer document
15. 01:20, 3 Dec 2024 (diff | hist) Fmoc chemistry 3,388 ±0 m fix a broken wikilink